199327-61-2,
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one,
7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one,
Gefitinib Impurity 12,
7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one,
AK-47996,
A1-01421,
Q-101334,
7-Methoxy-6-(3-morpholinopropoxy)-quinazolin-4(3H)-one,
4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-,
7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one,
WFUBWLXSYCFZEH-UHFFFAOYSA-N,
SCHEMBL829762,
CTK0H3924,
DTXSID90439401,
7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one,
BCP26350,
KS-00000I4Z,
ANW-23857,
MFCD12760130,
ZINC22062324,
AKOS015917892,
AKOS025401601,
DS-1851,
OR45084,
RL02495,
AC-22622,
ACM199327612,
AJ-80907,
AN-30109,
SC-72020,
SY039369,
AB0000528,
AX8164143,
DB-066001,
ST2406577,
4CH-017695,
AM20090617,
FT-0660445,
X2633,
MFCD12760130 (95%),
A18404,
S-0018,
327M612,
I14-8804,
7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazol,
7-methoxy-6-(3-morpholinopropoxy)-1H-quinazolin-4-one,
7-Methoxy-6-(3-morpholinopropoxy)-4(3H)-quinazolinone,
7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(1h)-one,
7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-one,
7-methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin4-one,
7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(1H)-quinazolinone,
7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone,
7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(1H)-one,
7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(3H)-one,
7-methoxy-6-[3-(morpholin-4-yl)propoxy]-3,4-dihydroquinazolin-4-one,
Morfon,
C16H21N3O4,
ACN-028885,
CID10403660,
EC 429-400-7,
4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-,
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0.5 % formamide (EC No 200-842-0)]7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing >= 0.5 % formamide (EC No 200-842-0)],